Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 03/54
Orrin
Hatch
U.S. Senate · R-UT
Taken from pharma & insurers
$222,270
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 03/54
Pharma & Health$203,270
Insurers & HMOs$19,000
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 3 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$222,270
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
After office
We checked the public record. No industry job, board seat, or gift after this vote.
Sometimes the vote really is free.
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
★ Hall of Shame
Hatch voted with the money in more than one set:
Don't recognize a logo? Here's the key.
Pharma & Health$203,270
Amgen$50,420
Eli Lilly$48,700
Pfizer$35,700
Merck$24,100
Johnson & Johnson$18,750
PhRMA$16,000
Bristol Myers Squibb$9,600
Insurers & HMOs$19,000
Centene$10,000
AHIP$5,000
Cigna$2,500
Aetna$1,000
Humana$500